佛慈制药
(002644)
| 流通市值：41.98亿 | | | 总市值：41.98亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 565,242,741.32 | 524,492,565.97 | 448,669,550.41 | 384,119,508.08 |
| 应收票据及应收账款 | 384,100,347 | 383,610,607.07 | 395,826,835.54 | 426,418,270.12 |
| 其中：应收票据 | 60,503,666.27 | 81,676,070.22 | 60,887,119.01 | 88,032,040.23 |
| 应收账款 | 323,596,680.73 | 301,934,536.85 | 334,939,716.53 | 338,386,229.89 |
| 应收款项融资 | 75,520,290.88 | 90,470,290.93 | 75,579,255.51 | 36,620,776.83 |
| 预付款项 | 7,336,923.69 | 7,805,349.28 | 13,849,133.29 | 15,386,203.07 |
| 其他应收款合计 | 3,899,833.26 | 3,281,823.48 | 21,414,633.18 | 23,259,047.02 |
| 存货 | 293,807,934.6 | 289,840,463.5 | 335,845,283.56 | 352,833,168.29 |
| 其他流动资产 | 33,254,388.68 | 33,240,036.88 | 31,643,749.32 | 33,631,316.02 |
| 流动资产合计 | 1,363,162,459.43 | 1,332,741,137.11 | 1,322,828,440.81 | 1,272,268,289.43 |
| 非流动资产: | | | | |
| 长期股权投资 | 47,914,020.88 | 49,934,022.03 | 50,048,818.67 | 51,741,397.14 |
| 其他权益工具投资 | 20,000,000 | 20,000,000 | - | - |
| 投资性房地产 | 6,390,443.2 | 6,494,922.95 | 6,992,458.95 | 7,096,938.7 |
| 固定资产 | 972,827,532.59 | 984,392,869.44 | 987,758,000.4 | 1,004,149,811.85 |
| 在建工程 | - | - | 1,764,636.34 | 1,764,636.34 |
| 使用权资产 | 3,282,317.4 | 2,572,114.75 | 1,346,560.42 | 1,445,720.08 |
| 无形资产 | 72,727,872.48 | 73,552,867.49 | 74,388,906.24 | 75,287,209.05 |
| 商誉 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 |
| 长期待摊费用 | 1,784,199.87 | 1,842,096.14 | 2,358,607.93 | 2,222,209.46 |
| 递延所得税资产 | 65,681,475.53 | 65,792,793.16 | 65,761,494.9 | 63,329,018.26 |
| 其他非流动资产 | 676,273.19 | 1,164,067.12 | 1,700,397.29 | 2,134,557.29 |
| 非流动资产合计 | 1,200,293,721.98 | 1,214,755,339.92 | 1,201,129,467.98 | 1,218,181,085.01 |
| 资产总计 | 2,563,456,181.41 | 2,547,496,477.03 | 2,523,957,908.79 | 2,490,449,374.44 |
| 流动负债: | | | | |
| 短期借款 | 17,800,000 | 21,695,344.44 | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 294,127,627.74 | 263,627,358.43 | 267,619,802.02 | 226,089,882.91 |
| 其中：应付票据 | 46,352,087 | 36,152,494.37 | 13,339,105.37 | - |
| 应付账款 | 247,775,540.74 | 227,474,864.06 | 254,280,696.65 | 226,089,882.91 |
| 合同负债 | 50,664,548.69 | 50,754,840.76 | 37,283,586.53 | 37,797,702.98 |
| 应付职工薪酬 | 1,335,762.16 | 1,781,872.22 | 1,109,425.12 | 1,335,171.26 |
| 应交税费 | 20,345,723.64 | 26,265,770.81 | 10,194,886.41 | 11,020,288.4 |
| 其他应付款合计 | 44,324,733.04 | 36,524,878.99 | 50,455,880.96 | 64,899,818.36 |
| 一年内到期的非流动负债 | 2,392,013.95 | 16,088,002.55 | 14,330,249.88 | 14,597,301.99 |
| 其他流动负债 | 16,852,336.63 | 23,883,390.98 | 35,180,210.07 | 31,751,346.95 |
| 流动负债合计 | 447,842,745.85 | 440,621,459.18 | 426,174,040.99 | 397,491,512.85 |
| 非流动负债: | | | | |
| 长期借款 | 6,200,000 | 6,200,000 | 5,800,000 | 3,000,000 |
| 租赁负债 | 2,286,704.33 | 1,510,061.48 | 1,844,240.38 | 1,338,702.96 |
| 递延收益 | 236,288,913.47 | 241,401,060.32 | 241,723,065.17 | 246,975,363.52 |
| 递延所得税负债 | 2,254,701.41 | 2,299,631.24 | 2,471,426.34 | 2,802,235.02 |
| 非流动负债合计 | 247,030,319.21 | 251,410,753.04 | 251,838,731.89 | 254,116,301.5 |
| 负债合计 | 694,873,065.06 | 692,032,212.22 | 678,012,772.88 | 651,607,814.35 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 510,657,000 | 510,657,000 | 510,657,000 | 510,657,000 |
| 资本公积 | 327,393,806.93 | 337,393,806.93 | 337,393,806.93 | 337,393,806.93 |
| 其他综合收益 | -36,799 | -36,799 | 32,159 | 32,159 |
| 专项储备 | 694,022.13 | 700,479.68 | 952,250.19 | 952,250.19 |
| 盈余公积 | 132,732,219.9 | 132,732,219.9 | 126,006,345.3 | 126,006,345.3 |
| 未分配利润 | 873,883,857.54 | 851,222,610.13 | 846,823,689.7 | 838,845,929.65 |
| 归属于母公司股东权益合计 | 1,845,324,107.5 | 1,832,669,317.64 | 1,821,865,251.12 | 1,813,887,491.07 |
| 少数股东权益 | 23,259,008.85 | 22,794,947.17 | 24,079,884.79 | 24,954,069.02 |
| 股东权益合计 | 1,868,583,116.35 | 1,855,464,264.81 | 1,845,945,135.91 | 1,838,841,560.09 |
| 负债和股东权益合计 | 2,563,456,181.41 | 2,547,496,477.03 | 2,523,957,908.79 | 2,490,449,374.44 |
| 公告日期 | 2026-04-30 | 2026-04-09 | 2025-10-29 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |